|
May 9
|
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
|
|
May 9
|
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
|
|
May 8
|
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue Estimates
|
|
May 8
|
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
|
|
May 8
|
CRISPR Therapeutics Highlights ASGCT Oral Presentation and Announces New Programs Utilizing In Vivo Gene Editing Approach
|
|
May 6
|
CRISPR (CRSP) to Report Q1 Earnings: What's in the Cards?
|
|
May 4
|
3 Biotech Stocks With the Potential to Make You an Overnight Millionaire
|
|
May 3
|
Shhh! 3 Secret Gene Editing Stocks Flying Below Wall Street’s Radar
|
|
May 2
|
3 Biotech Stocks to Buy and Hold Through 2030 and Beyond
|
|
May 2
|
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
|
|
May 1
|
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
|
|
May 1
|
Here is What to Know Beyond Why CRISPR Therapeutics AG (CRSP) is a Trending Stock
|
|
Apr 26
|
CRISPR Therapeutics AG (CRSP) Ascends But Remains Behind Market: Some Facts to Note
|
|
Apr 25
|
Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
|
|
Apr 22
|
CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: Here's Why
|
|
Apr 22
|
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
|
|
Apr 22
|
Cathie Wood’s Latest Stock Portfolio: Top 10 Stock Picks
|
|
Apr 20
|
CRISPR Therapeutics Stock (NASDAQ:CRSP) Pushes Lower, But Fundamentals Are Intact
|
|
Apr 19
|
ChatGPT Stock Predictions: 10 Stocks That Have 10X Potential
|
|
Apr 17
|
Is Trending Stock CRISPR Therapeutics AG (CRSP) a Buy Now?
|